MICHAEL ELLIOT KUPFERMAN to Combined Modality Therapy
This is a "connection" page, showing publications MICHAEL ELLIOT KUPFERMAN has written about Combined Modality Therapy.
Connection Strength
0.602
-
Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations. Head Neck. 2017 02; 39(2):E20-E22.
Score: 0.060
-
Cutaneous malignancy of the head and neck. Surg Oncol Clin N Am. 2015 Jul; 24(3):593-613.
Score: 0.054
-
Optimization of long-term outcomes for patients with esthesioneuroblastoma. Head Neck. 2014 Apr; 36(4):524-30.
Score: 0.048
-
Primary sarcomas of the salivary glands: case series and literature review. Head Neck. 2013 Nov; 35(11):1551-7.
Score: 0.048
-
The role of trastuzumab in the management of salivary ductal carcinomas. Anticancer Res. 2013 Jun; 33(6):2587-91.
Score: 0.048
-
Multimodality treatment for sinonasal neuroendocrine carcinoma. Head Neck. 2012 Oct; 34(10):1372-6.
Score: 0.043
-
Malignant head and neck paragangliomas: is there an optimal treatment strategy? Head Neck Oncol. 2010 Sep 23; 2:23.
Score: 0.040
-
Outcomes of pediatric patients with malignancies of the major salivary glands. Ann Surg Oncol. 2010 Dec; 17(12):3301-7.
Score: 0.039
-
The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer. 2007 May 15; 109(10):2052-7.
Score: 0.031
-
Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series. Curr Oncol. 2022 09 14; 29(9):6540-6550.
Score: 0.023
-
Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2021 05 01; 134(5):1392-1398.
Score: 0.019
-
Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies. Laryngoscope. 2020 01; 130(1):86-93.
Score: 0.018
-
Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605.
Score: 0.017
-
Site-Specific Considerations in the Surgical Management of Skull Base Chondrosarcomas. Oper Neurosurg (Hagerstown). 2018 06 01; 14(6):611-619.
Score: 0.017
-
Impact of early access to multidisciplinary care on treatment outcomes in patients with skull base chordoma. Acta Neurochir (Wien). 2018 04; 160(4):731-740.
Score: 0.016
-
Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017 08; 39(8):1671-1679.
Score: 0.016
-
Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys. 2016 09 01; 96(1):30-41.
Score: 0.015
-
Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study. JAMA Otolaryngol Head Neck Surg. 2015 Dec; 141(12):1043-1051.
Score: 0.014
-
Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg. 2015 Sep; 123(3):781-8.
Score: 0.014
-
Esthesioneuroblastoma. Neurosurg Clin N Am. 2013 Jan; 24(1):51-65.
Score: 0.012
-
Induction chemotherapy for advanced squamous cell carcinoma of the paranasal sinuses. Arch Otolaryngol Head Neck Surg. 2011 Jan; 137(1):78-81.
Score: 0.010